"There will not be any research funded by NIH on mRNA vaccines," the scientist in New York similarly told the outlet. "MAGA people are convinced that these vaccines have killed and maimed tens of ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company ...

DOPE-Cx can form a special structure called a "cubic phase," which helps overcome a major challenge in mRNA delivery by LNPs ... with specific hydrophobic chain structures induce non-lamellar ...

As noted in the report by Fosun International Securities: AIM's mRNA platform "maintains vaccine activity under conventional cold chain conditions of 2-8°C through optimized nucleotide ...

Spray-drying represents a well-established technique that addresses solubility and other manufacturing and stability challenges.

or collaborations involving mRNA vaccines be reported up the chain to Health and Human Services Secretary Robert F. Kennedy Jr."s office and the White House. Memoli sent a similar message ahead of ...

German biotech Ethris, a company developing RNA therapeutics and vaccines, and Swiss contract development and manufacturing ...

or collaborations involving mRNA vaccines be reported up the chain to Health and Human Services Secretary Robert F. Kennedy Jr.’s office and the White House. Memoli sent a similar message ahead ...

Scientists at Shinshu University School of Medicine have developed a synthetic mRNA that, when injected, revitalizes the immune system to recognize and attack metastasizing cancer cells.

or collaborations involving mRNA vaccines be reported up the chain to Health and Human Services Secretary Robert F. Kennedy Jr.'s office and the White House. Memoli sent a similar message ahead of ...